Evidence map›Paper›PMID 35136410›Full record

ArticleJournal of oncology2022

Components of

Nadezda Lachej, Daiva Dabkeviciene, Julija Simiene, Rasa Sabaliauskaite, Violeta Jonusiene, Vytautas Brasiunas, Ausra Sasnauskiene, Ieva Vaicekauskaite, Birute Brasiuniene, Daiva Kanopiene and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Role of signaling pathways in endometrial cancer.Molecular biology reports · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nadezda LachejClinic of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-10257 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-3948-6285
Daiva DabkevicieneNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0001-5202-220X
Julija SimieneNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0001-9358-8859
Rasa SabaliauskaiteNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-3465-3558
Violeta JonusieneInstitute of Biosciences, Life Sciences Center, Vilnius University, LT-08412 Vilnius, Lithuania.ORCID https://orcid.org/0000-0003-4614-3595
Vytautas BrasiunasNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-3463-8999
Ausra SasnauskieneInstitute of Biosciences, Life Sciences Center, Vilnius University, LT-08412 Vilnius, Lithuania.ORCID https://orcid.org/0000-0003-3261-7622
Ieva VaicekauskaiteNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0003-3536-4384
Birute BrasiunieneClinic of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-10257 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-7097-1131
Daiva KanopieneNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-5207-7013
Kestutis SuziedelisNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-9485-3674
Janina DidziapetrieneNational Cancer Institute, LT-08660 Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-6807-8395
Vilnius University · LTNational Cancer Institute · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New molecular biomarkers that could have an independent prognostic value in endometrial cancer are currently under investigation. Recently, it was suggested that genetic changes in the Notch signaling pathway could be associated with the development of endometrial carcinoma. This study aimed to determine the expression of the Notch signaling pathway components in tumour and adjacent normal uterine tissue and to evaluate their importance for the survival of uterine cancer patients. The present study was performed on uterine body samples collected from 109 patients and paired adjacent noncancerous endometrial tissue samples. Kaplan-Meier curves and Cox regression were used for survival analyses. Expression alterations of

Identifiers

PMID35136410
PMCPMC8818413
OpenAlexW4210311010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.